Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 49
Results: 11
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 6989, doi. 10.1038/sj.onc.1210500
- By:
- Publication type:
- Article
Sensitization of pancreatic carcinoma cells for γ-irradiation-induced apoptosis by XIAP inhibition.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 7006, doi. 10.1038/sj.onc.1210502
- By:
- Publication type:
- Article
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 6968, doi. 10.1038/sj.onc.1210503
- By:
- Publication type:
- Article
Overexpression of p101 activates PI3Kγ signaling in T cells and contributes to cell survival.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 7049, doi. 10.1038/sj.onc.1210504
- By:
- Publication type:
- Article
Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 7028, doi. 10.1038/sj.onc.1210505
- By:
- Publication type:
- Article
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 6997, doi. 10.1038/sj.onc.1210506
- By:
- Publication type:
- Article
Human p16γ, a novel transcriptional variant of p16<sup>INK4A</sup>, coexpresses with p16<sup>INK4A</sup> in cancer cells and inhibits cell-cycle progression.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 7017, doi. 10.1038/sj.onc.1210507
- By:
- Publication type:
- Article
The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 6979, doi. 10.1038/sj.onc.1210508
- By:
- Publication type:
- Article
Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 7038, doi. 10.1038/sj.onc.1210510
- By:
- Publication type:
- Article
The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 7058, doi. 10.1038/sj.onc.1210514
- By:
- Publication type:
- Article
Eighth International Mesothelioma Interest Group.
- Published in:
- Oncogene, 2007, v. 26, n. 49, p. 6959, doi. 10.1038/sj.onc.1210515
- By:
- Publication type:
- Article